Joy Melnikow, MD, MPH
Melnikow J. Review: Tamoxifen, raloxifene, and tibolone prevent primary invasive breast cancer but increase risk for adverse outcomes. Ann Intern Med. 2010;152:JC3–4. doi: 10.7326/0003-4819-152-6-201003160-02004
Download citation file:
Published: Ann Intern Med. 2010;152(6):JC3-4.
Breast Cancer, Hematology/Oncology, Prevention/Screening.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use